AU2001263215A1 - Method for treating cartilage disorders - Google Patents
Method for treating cartilage disordersInfo
- Publication number
- AU2001263215A1 AU2001263215A1 AU2001263215A AU6321501A AU2001263215A1 AU 2001263215 A1 AU2001263215 A1 AU 2001263215A1 AU 2001263215 A AU2001263215 A AU 2001263215A AU 6321501 A AU6321501 A AU 6321501A AU 2001263215 A1 AU2001263215 A1 AU 2001263215A1
- Authority
- AU
- Australia
- Prior art keywords
- igf
- cartilage
- cartilage disorders
- treating cartilage
- igfbp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title abstract 3
- 208000015100 cartilage disease Diseases 0.000 title abstract 2
- 102000028416 insulin-like growth factor binding Human genes 0.000 abstract 4
- 108091022911 insulin-like growth factor binding Proteins 0.000 abstract 4
- 102100037852 Insulin-like growth factor I Human genes 0.000 abstract 2
- 210000000845 cartilage Anatomy 0.000 abstract 2
- 206010061762 Chondropathy Diseases 0.000 abstract 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4743—Insulin-like growth factor binding protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20449000P | 2000-05-16 | 2000-05-16 | |
US60204490 | 2000-05-16 | ||
US24898500P | 2000-11-15 | 2000-11-15 | |
US60248985 | 2000-11-15 | ||
PCT/US2001/015904 WO2001087323A2 (en) | 2000-05-16 | 2001-05-16 | Method for treating cartilage disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001263215A1 true AU2001263215A1 (en) | 2001-11-26 |
Family
ID=26899527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001263215A Abandoned AU2001263215A1 (en) | 2000-05-16 | 2001-05-16 | Method for treating cartilage disorders |
Country Status (9)
Country | Link |
---|---|
US (4) | US20030069177A1 (de) |
EP (1) | EP1282437B1 (de) |
AT (1) | ATE389416T1 (de) |
AU (1) | AU2001263215A1 (de) |
DE (1) | DE60133271T2 (de) |
DK (1) | DK1282437T3 (de) |
ES (1) | ES2301547T3 (de) |
HK (1) | HK1050321A1 (de) |
WO (1) | WO2001087323A2 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1099443A1 (de) | 1999-11-11 | 2001-05-16 | Sulzer Orthopedics Ltd. | Transplantations/Implantatsvorrichtung und ihre Herstellungsmethode |
US7387889B2 (en) * | 2002-08-22 | 2008-06-17 | Massachusetts Institute Of Technology | Measurement of concentrations and binding energetics |
US8173162B2 (en) * | 2003-02-26 | 2012-05-08 | Zimmer Orthobiologics, Inc. | Preparation for repairing cartilage tissue, especially articular cartilage defects |
US20070275032A1 (en) * | 2004-03-05 | 2007-11-29 | Synthes (U.S.A.) | Use Of A Mixture For The Production Of An Agent For Treating Defective Or Degenerated Cartilage In The Production Of Natural Cartilage Replacement In Vitro |
WO2005122723A2 (en) * | 2004-06-09 | 2005-12-29 | Beth Israel Deaconess Medical Center | Compositions and methods that enhance articular cartilage repair |
EP1764117A1 (de) | 2005-09-20 | 2007-03-21 | Zimmer GmbH | Implantat zur Wiederherstellung von Knorpeldefekten und Verfahren zu seiner Herstellung |
CN102389344B (zh) | 2006-02-07 | 2015-12-16 | 脊柱赛特有限公司 | 采用机械应变使人皮肤成纤维细胞发生软骨形成分化的方法 |
CL2007002502A1 (es) * | 2006-08-31 | 2008-05-30 | Hoffmann La Roche | Variantes del factor de crecimiento similar a insulina-1 humano (igf-1) pegilados en lisina; metodo de produccion; proteina de fusion que la comprende; y su uso para tratar la enfermedad de alzheimer. |
GEP20125659B (en) * | 2006-12-29 | 2012-10-10 | Ipsen Pharma Sas | Pharmaceutical compositions containing glucagon-like peptide-1 (glp-1) |
WO2010041636A1 (ja) | 2008-10-06 | 2010-04-15 | 株式会社スリー・ディー・マトリックス | 組織閉塞剤 |
KR102165021B1 (ko) | 2008-12-19 | 2020-10-14 | 박스알타 인코퍼레이티드 | Tfpi 억제제 및 사용 방법 |
JP5730983B2 (ja) | 2010-03-19 | 2015-06-10 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | Tfpi阻害剤および使用方法 |
CN108014339A (zh) * | 2011-11-09 | 2018-05-11 | 脊核细胞有限责任公司 | 用于治疗椎间盘退变性疾病的成纤维细胞 |
SI2827883T1 (sl) | 2012-03-21 | 2019-08-30 | Baxalta GmbH | Inhibitorji TFPI in postopki uporabe |
US9637531B2 (en) * | 2012-06-25 | 2017-05-02 | The Brigham And Women's Hospital, Inc | Selective cartilage therapy |
EP3466964A1 (de) | 2012-07-06 | 2019-04-10 | 3-D Matrix Ltd. | Füllabschlussverfahren für peptidlösungen |
WO2014204806A2 (en) | 2013-06-19 | 2014-12-24 | Spinalcyte, Llc | Adipose cells for chondrocyte applications |
US10245299B2 (en) | 2014-03-10 | 2019-04-02 | 3-D Matrix, Ltd. | Autoassembling peptides for the treatment of pulmonary bulla |
WO2015138514A1 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Self-assembling peptide compositions |
WO2015136370A2 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Sterilization and filtration of peptide compositions |
US10814038B2 (en) | 2016-01-06 | 2020-10-27 | 3-D Matrix, Ltd. | Combination compositions |
US11324703B2 (en) | 2017-12-15 | 2022-05-10 | 3-D Matrix, Ltd. | Surfactant peptide nanostructures and uses thereof in drug delivery |
Family Cites Families (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4411890A (en) * | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US3721252A (en) * | 1971-04-01 | 1973-03-20 | Catheter And Instr Corp | Spring guide washer |
US4444047A (en) * | 1979-06-29 | 1984-04-24 | Vdo Adolf Schindling A.G. | Apparatus for determining the fuel consumption of injection internal combustion engines |
EP0023469B1 (de) | 1979-07-16 | 1983-07-20 | Ciba-Geigy Ag | Nachbehandlung von mit Flammschutzmitteln veredelten, cellulosehaltigen Fasermaterialien mit flüssigem Ammoniak |
US4511503A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
IL71991A (en) | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
WO1985000831A1 (en) | 1983-08-10 | 1985-02-28 | Amgen | Microbial expression of insulin-like growth factor |
ATE81779T1 (de) * | 1985-08-22 | 1992-11-15 | Gropep Pty Ltd | Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren. |
PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
SE8505922D0 (sv) | 1985-12-13 | 1985-12-13 | Kabigen Ab | Construction of an igg binding protein to facilitate downstream processing using protein engineering |
ATE90690T1 (de) | 1987-04-06 | 1993-07-15 | Celtrix Pharma | Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung. |
ES2007309T3 (es) | 1987-04-23 | 1994-11-01 | Monsanto Co | Secrecion del factor de crecimiento insulinoide 1 en e.coli. |
SE8703625D0 (sv) * | 1987-09-18 | 1987-09-18 | Kabivitrum Ab | New medical use |
US4876242A (en) * | 1987-09-21 | 1989-10-24 | Merck & Co., Inc. | Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast |
DE3852636T2 (de) | 1987-12-24 | 1995-05-04 | Gropep Pty Ltd | Peptid-analoge vom insulinähnlichen wachstums-faktor 1 (igf-1) oder faktor 2 (igf-2). |
US5470828A (en) * | 1987-12-24 | 1995-11-28 | Gropep Pty. Ltd. | Peptide analogs of insulin-like growth factor II |
US4988675A (en) * | 1988-02-05 | 1991-01-29 | Ciba-Geigy Corporation | Method for preventing secondary effects |
EP0327503B1 (de) * | 1988-02-05 | 1993-03-10 | Ciba-Geigy Ag | Verwendung von IGF I zur Herstellung eines Präparates für die Behandlung von Nierenkrankheiten |
DK131988A (da) | 1988-03-11 | 1989-09-12 | Erasmus University | Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur |
US5258287A (en) | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
WO1989009792A1 (en) | 1988-04-12 | 1989-10-19 | Synergen, Inc. | Method for potentiating and inhibiting insulin-like growth factor activity |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US6780613B1 (en) * | 1988-10-28 | 2004-08-24 | Genentech, Inc. | Growth hormone variants |
US5534617A (en) * | 1988-10-28 | 1996-07-09 | Genentech, Inc. | Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 |
GB8826451D0 (en) | 1988-11-11 | 1988-12-14 | Sandoz Ltd | Improvements in/relating to organic compounds |
IL92816A0 (en) | 1988-12-22 | 1990-09-17 | Biogrowth Inc | Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides |
CA2007886A1 (en) | 1989-01-17 | 1990-07-17 | Marvin L. Bayne | Human insulin-like growth factor analogs with reduced binding to 28 k igf binding proteins and their production in yeast |
US5514646A (en) * | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain |
US5652214A (en) * | 1989-06-05 | 1997-07-29 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factors and analogs |
US5093317A (en) * | 1989-06-05 | 1992-03-03 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factor |
GB8920381D0 (en) | 1989-09-08 | 1989-10-25 | Greater Glasgow Health Board | Treatment of insulin-resistant diabetes |
SE500903C2 (sv) | 1989-12-20 | 1994-09-26 | Atlas Copco Constr & Mining | Bergborrningsrigg |
ZA9010332B (en) | 1989-12-22 | 1991-08-28 | Ciba Geigy | Method of reducing or preventing adverse effect of steroid therapy and compositions therefor |
NZ236618A (en) | 1990-01-03 | 1997-06-24 | Ciba Geigy Ag | Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound |
US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
US5374620A (en) * | 1990-06-07 | 1994-12-20 | Genentech, Inc. | Growth-promoting composition and its use |
US5364839A (en) | 1990-06-18 | 1994-11-15 | Genetics Institute, Inc. | Osteoinductive pharmaceutical formulations |
US5210017A (en) | 1990-11-19 | 1993-05-11 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
US5593844A (en) | 1990-11-19 | 1997-01-14 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
EP0564531B1 (de) * | 1990-12-03 | 1998-03-25 | Genentech, Inc. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
SE9100099D0 (sv) | 1991-01-11 | 1991-01-11 | Kabi Pharmacia Ab | Use of growth factor |
US5206023A (en) | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
US5187151A (en) * | 1991-02-12 | 1993-02-16 | Genentech, Inc. | Use of binding protein with igf-i as an anabolic growth promoting agent |
JP4146512B2 (ja) | 1991-03-01 | 2008-09-10 | ダイアックス コープ. | 小型タンパク質 |
US5206235A (en) * | 1991-03-20 | 1993-04-27 | Merck & Co., Inc. | Benzo-fused lactams that promote the release of growth hormone |
US5202119A (en) * | 1991-06-28 | 1993-04-13 | Genentech, Inc. | Method of stimulating immune response |
DK0597033T3 (da) * | 1991-08-01 | 1997-06-02 | Genentech Inc | IGF-1 til forbedring af den neurale tilstand |
US6310040B1 (en) | 1991-11-08 | 2001-10-30 | Cephalon, Inc. | Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
TW267102B (de) | 1992-03-13 | 1996-01-01 | Ciba Geigy | |
SE9201573D0 (sv) * | 1992-05-19 | 1992-05-19 | Kabi Pharmacia Ab | Use of igf-1 |
HU217543B (hu) * | 1992-06-12 | 2000-02-28 | Albert Einstein College Of Medicine Of Yeshiva University | Eljárás perifériás neuropátia kezelésére és megelőzésére alkalmas gyógyászati készítmények előállítására, valamint inzulinszerű növekedési faktor I-et és kemoterápiás szert tartalmazó gyógyászati készítmények |
GB9217696D0 (en) | 1992-08-20 | 1992-09-30 | Agricultural & Food Res | Use of specific binding molecules |
US5273961A (en) * | 1992-09-22 | 1993-12-28 | Genentech, Inc. | Method of prophylaxis of acute renal failure |
US5342763A (en) * | 1992-11-23 | 1994-08-30 | Genentech, Inc. | Method for producing polypeptide via bacterial fermentation |
JPH08500123A (ja) | 1993-01-25 | 1996-01-09 | ザ ベス イスラエル ホスピタル アソシエイション | Igf−i感受性細胞のバリヤー特性の修飾方法,診断方法及びスクリーニング方法 |
CA2154078A1 (en) | 1993-01-29 | 1994-08-04 | George N. Cox | Wound healing composition |
US5457109A (en) | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
CN1052730C (zh) | 1993-12-23 | 2000-05-24 | 诺沃挪第克公司 | 具有生长激素释放特性的化合物 |
WO1995017423A1 (en) | 1993-12-23 | 1995-06-29 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US5597700A (en) * | 1994-04-28 | 1997-01-28 | California Research, Llc | Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method |
US5444047A (en) | 1994-06-16 | 1995-08-22 | Dipasquale; Gene | Treatment of arthritic and post-surgical orthopedic conditions with Insulin-like Growth Factor-I |
SE9402331D0 (sv) * | 1994-07-01 | 1994-07-01 | Pharmacia Ab | New use |
SE9402370D0 (sv) | 1994-07-04 | 1994-07-04 | Pharmacia Ab | Use of IGF-I |
US5712249A (en) * | 1994-09-08 | 1998-01-27 | Ciba-Geigy Corporation | Use of insulin-like growth factors I and II for inhibition of inflammatory response |
US5798337A (en) | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
US5596844A (en) * | 1995-02-03 | 1997-01-28 | Kalinowski; Juan R. | Foldable portable building |
SE9501472D0 (sv) | 1995-04-21 | 1995-04-21 | Pharmacia Ab | Truncated IGF-I |
US5622932A (en) | 1995-05-05 | 1997-04-22 | Eli Lilly And Company | IGF-1 superagonists |
US5741776A (en) * | 1995-05-22 | 1998-04-21 | Genentech, Inc. | Method of administration of IGF-I |
US5565428A (en) * | 1995-05-22 | 1996-10-15 | Genentech, Inc. | Method of administration of IGF-I |
ES2163020T3 (es) | 1995-05-26 | 2002-01-16 | Theratechnologies Inc | Analogos quimericos de factor liberador de hormona de crecimiento (grf) de cuerpo graso, provistos de mayor potencia biologica. |
EP2055712A1 (de) | 1995-06-07 | 2009-05-06 | Glaxo Group Limited | Peptide und Verbindungen, die einen Thrombopoietin-Rezeptor binden |
WO1996040189A1 (en) | 1995-06-07 | 1996-12-19 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
US5958872A (en) | 1996-04-01 | 1999-09-28 | Apoptosis Technology, Inc. | Active survival domains of IGF-IR and methods of use |
AU2676297A (en) | 1996-04-17 | 1997-11-07 | Neurocrine Biosciences, Inc. | Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor |
CA2265972A1 (en) * | 1996-09-16 | 1998-03-26 | Philip D. Acott | Use of igf-i for the treatment of polycystic kidney disease and related indications |
EP0938497B1 (de) | 1996-11-06 | 2007-02-28 | Genentech, Inc. | Gespannte, helixformende peptide und verfahren um sie herzustellen |
AU7891098A (en) | 1996-12-27 | 1998-07-31 | Daiichi Pharmaceutical Co., Ltd. | Method for elevating the concentration of free insulin-like growth factor |
US6121416A (en) * | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
ZA984697B (en) | 1997-06-13 | 1999-12-01 | Lilly Co Eli | Stable insulin formulations. |
DE19757250A1 (de) | 1997-12-22 | 1999-07-01 | Forssmann Wolf Georg Prof Dr | Insulin-like growth factor binding protein und seine Verwendung |
EP1067959A2 (de) * | 1998-04-03 | 2001-01-17 | Chiron Corporation | Verwendung von igf1 zur behandlng von knorpelkrankheiten |
AU767141B2 (en) | 1998-10-02 | 2003-10-30 | Celtrix Pharmaceuticals, Inc. | Null IGF for the treatment of cancer |
AU6515499A (en) | 1998-10-16 | 2000-05-08 | Musc Foundation For Research Development | Fragments of insulin-like growth factor binding protein and insulin-like growth factor, and uses thereof |
DE60042550D1 (de) * | 1999-01-06 | 2009-08-27 | Genentech Inc | Mutierte varianten des insulin-ähnlichen wachstumsfaktor i (igf-i) |
JP2003518917A (ja) | 1999-05-19 | 2003-06-17 | ゼンコー | 糖尿病の処置に有用なインシュリン様活性を有する新規タンパク質 |
AU2000239309A1 (en) | 2000-03-29 | 2001-10-08 | Dgi Biotechnologies Llc | Insulin and igf-1 receptor agonists and antagonists |
-
2001
- 2001-05-16 ES ES01937482T patent/ES2301547T3/es not_active Expired - Lifetime
- 2001-05-16 DE DE60133271T patent/DE60133271T2/de not_active Expired - Lifetime
- 2001-05-16 DK DK01937482T patent/DK1282437T3/da active
- 2001-05-16 AT AT01937482T patent/ATE389416T1/de active
- 2001-05-16 WO PCT/US2001/015904 patent/WO2001087323A2/en active Application Filing
- 2001-05-16 EP EP01937482A patent/EP1282437B1/de not_active Expired - Lifetime
- 2001-05-16 AU AU2001263215A patent/AU2001263215A1/en not_active Abandoned
- 2001-05-16 US US09/858,935 patent/US20030069177A1/en not_active Abandoned
-
2002
- 2002-10-16 US US10/271,869 patent/US7423017B2/en not_active Expired - Fee Related
-
2003
- 2003-04-04 HK HK03102436A patent/HK1050321A1/xx not_active IP Right Cessation
-
2007
- 2007-10-30 US US11/929,468 patent/US7947650B2/en not_active Expired - Fee Related
- 2007-11-02 US US11/934,582 patent/US8110548B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2301547T3 (es) | 2008-07-01 |
US20030211992A1 (en) | 2003-11-13 |
DE60133271D1 (de) | 2008-04-30 |
US8110548B2 (en) | 2012-02-07 |
DE60133271T2 (de) | 2009-04-23 |
EP1282437B1 (de) | 2008-03-19 |
US7423017B2 (en) | 2008-09-09 |
ATE389416T1 (de) | 2008-04-15 |
US20090011988A1 (en) | 2009-01-08 |
WO2001087323A3 (en) | 2002-04-11 |
HK1050321A1 (en) | 2003-06-20 |
US7947650B2 (en) | 2011-05-24 |
WO2001087323A2 (en) | 2001-11-22 |
US20100130411A1 (en) | 2010-05-27 |
US20030069177A1 (en) | 2003-04-10 |
EP1282437A2 (de) | 2003-02-12 |
DK1282437T3 (da) | 2008-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001263215A1 (en) | Method for treating cartilage disorders | |
WO2002072780A3 (en) | Igf antagonist peptides | |
WO1998045427A3 (en) | Insulin-like growth factor agonist peptides | |
DE69334266D1 (de) | Therapeutische Zusammensetzungen aus Antikorper und Antisens Nukleinsäuren gegen Serrate | |
CA2189657A1 (fr) | Fractions polypeptidiques solubles de la proteine lag-3; procede de production; composition therapeutique; anticorps anti-idiotype | |
DE69434875D1 (de) | BMP-11 Zusammenstellungen | |
ATE297202T1 (de) | Verwendung von nichtimmununterdruckende verbindungen zur förderung von nervenregeneration | |
WO2000023469A3 (en) | Fragments of insulin-like growth factor binding protein and insulin-like growth factor, and uses thereof | |
AU3498189A (en) | Fibronectin binding protein | |
GB0202556D0 (en) | Novel Protein | |
WO2004053059A3 (en) | Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same | |
AU3793493A (en) | Therapeutic domains of von willebrand factor | |
AU1276399A (en) | Neuronal uses of bmp-11 | |
DE69840024D1 (de) | Antimikrobielle Peptide, abstammend von Ubiquicidin | |
GB9509557D0 (en) | PCNA binding substance | |
PT781341E (pt) | Processo para a produção de proteínas recombinantes, plasmídeos e células modificadas | |
HUT64369A (en) | Collagen binding protein and method for producing it | |
ATE356145T1 (de) | Polypeptide zur regenerierung des nervensystems | |
WO2001072826A3 (en) | Oncogenic osteomalacia-related gene 1 | |
EP0801133A3 (de) | Hydroxyperoxide Lyasen | |
GB9416536D0 (en) | Orphan receptor | |
EP0816498A3 (de) | Exzitatorische Aminosäure Rezeptor-Protein und verwante Nukleinsäure | |
WO2001070808A3 (en) | Angiogenesis - associated proteins, and nucleic acids encoding the same | |
GB2357507A (en) | Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants | |
DE60040668D1 (de) | Antibakterielles protein chlamysin-b, dafür kodierendes gen und ein expresionssystem dafür |